Drug Reactions and Drug-Induced Skin Disease

Exanthematous (Maculopapular) Eruption

Features

•    Most common type of drug rash

•    Delayed type IV hypersensitivity (usually appears 5–14 days after starting drug)

•    Symmetrical, diffuse erythematous macules and papules

•    Typically starts on trunk spreads peripherally

•    No mucosal involvement

Common culprit drugs

•    Penicillins, cephalosporins

•    Sulfonamides

•    Anticonvulsants (e.g., phenytoin, carbamazepine)

Management

•    Stop offending drug

•    Symptomatic relief (topical steroids, antihistamines)


Urticaria and Angioedema

Features

•    Immediate (Type I) hypersensitivity

•    Urticaria: transient wheals, itching, resolves <24 h

•    Angioedema: deeper swelling, can involve airway (emergency)

Common culprit drugs

•    Penicillins

•    NSAIDs

•    Contrast media

•    ACE inhibitors (angioedema without urticaria — bradykinin-mediated)

Management

•    Stop drug

•    Antihistamines ± corticosteroids

•    Epinephrine if anaphylaxis suspected


Fixed Drug Eruption

Features

•    Well-defined erythematous or violaceous plaques

•    Recur at exact same site with re-exposure

•    Common sites: lips, genitals, hands

Common culprit drugs

•    NSAIDs

•    Tetracyclines

•    Sulfonamides

Management

•    Avoid culprit drug

•    Topical corticosteroids


Severe Cutaneous Adverse Reactions (SCARs)


Stevens–Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN)

•    Spectrum of same disease (SJS <10% BSA; TEN >30% BSA)

•    Extensive epidermal necrosis and detachment, mucosal involvement (>90% cases)

•    Positive Nikolsky’s sign

•    High mortality (TEN ~30–50%)

Common culprit drugs

•    Allopurinol

•    Anticonvulsants (lamotrigine, carbamazepine, phenytoin)

•    Sulfonamides

•    Nevirapine

•    NSAIDs (oxicams)

Management

•    Stop drug immediately

•    Supportive care in burns/ICU setting

•    IV fluids, wound care, infection prevention


DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms)

•    Fever, facial oedema, widespread rash

•    Eosinophilia, atypical lymphocytes

•    Organ involvement: liver (most common), kidney, lung

Common culprit drugs

•    Anticonvulsants

•    Allopurinol

•    Sulfonamides

Management

•    Stop drug

•    Systemic corticosteroids (in severe cases)


AGEP (Acute Generalised Exanthematous Pustulosis)

•    Numerous sterile, non-follicular pustules on erythematous background

•    Often starts in intertriginous areas

•    Associated fever, neutrophilia

•    Resolves rapidly after stopping drug

Common culprit drugs

•    Aminopenicillins

•    Macrolides

•    Calcium channel blockers

Management

•    Stop drug

•    Supportive treatment


Photosensitivity Reactions

Types

•    Phototoxic (more common): exaggerated sunburn

•    Photoallergic: eczematous reaction (type IV hypersensitivity)

Common culprit drugs

•    Tetracyclines (especially doxycycline)

•    Thiazides

•    Amiodarone

•    Fluoroquinolones

•    NSAIDs (piroxicam)

Management

•    Sun avoidance, protective clothing, high-factor sunscreen

•    Stop offending drug if possible


Extra Revision Pearls

•    Nikolsky’s sign positive think SJS/TEN, pemphigus vulgaris

•    DRESS: remember eosinophilia and hepatitis clue

•    AGEP: rapid onset pustules, resolves quickly after stopping drug

•    ACE inhibitor angioedema: bradykinin-mediated, not responsive to antihistamines/steroids

————————————————————————————————————————————————————————————————————————————————————————————————————————-

Author & Educational Disclaimer


Author:

Dr Phillip Cockrell BM FRCP DipClinEd


Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.


He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.


Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.


Purpose of this content:

The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.


Medical disclaimer:

This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.